Quetiapine (Standard & XL formulation)

Amber

Brand Name(s):Atrolak XL, Seroquel, Seroquel XL

Indication:Antipsychotic – patients NOT on the SMI register

Rationale:1,2

Considered:Oct-19

Review Date:Jul-25

Comments:
ESUOM12: Generalised anxiety disorder: quetiapine , see:
http://publications.nice.org.uk/esuom12-generalised-anxiety-disorder-quetiapine-esuom12
May 2013…………………………Revised SPCs: Atrolak (quetiapine fumarate) XL – SPC updated with warnings of increased risk of self-harm & suicide in patients 25- 64 yrs and increased risk of death in patients >65 years with Parkinson’s disease/parkinsonism. Stroke added as an adverse effect of treatment (of unknown frequency).prolonged-release tablets – all strengths.